Lishu He

Patient Care
- Find a Doctor
  Find a doctor by specialty or location.
- Care Locations
  Find primary and specialty care near you.
- Departments and Centers
  New knowledge driving discovery to advance the health of our communities.
- Research
  Every discovery advances academic medicine and improves the vitality of our communities.
- Pay a Bill
  Pay a a bill for services performed by MCW.
- Contact
  Let us help you find an answer to your question.
- MyChart Login
  MyChart user? Log in to make an appointment.
- Request an Appointment Online
  Or call Adult Specialties (800) 272-3666 or Pediatric Specialties (877) 607-5280.
Education
- Medical School
  Choose from a three or four-year MD program at various campus locations, our anesthesiologist assistant or a number of dual degree programs.
- Residency and Fellowship Programs
  Choose from more than 140 specialties and sub-specialties for advanced medical training at MCW.
- Graduate School
  Designed to provide a unique, specialized learning experience.
- PA/NP Fellowship and Residency Programs
  Innovative 12-month PA and NP transition to practice programs in a variety of specialty clinical tracks.
- Pharmacy School
  An innovative three-year PharmD program designed for the expanding pharmacist role in patient care.
- Continuing Professional Development (CME)
  Develops applied learning experiences and supports continual education of the healthcare professional beyond graduation.
- Commencement
  MCW Commencement Events – All Campuses
Research
- Basic Science Research
  Our scientists are discovery-drivers, working to develop cutting-edge treatments.
- Clinical Trials
  Clinical trials are invaluable in testing new treatments, drugs and technologies.
- Translational Research
  Translational scientists turn science and research into improved treatments.
- Centers
  Through collaboration with the brightest minds in science and medicine MCW’s Centers are at the forefront of discovery and innovation.
- Continuing Professional Development (CME)
  Develops applied learning experiences and supports continual education of the healthcare professional beyond graduation.
Community
- Advancing a Healthier Wisconsin Endowment
  Through research, health care education, workforce development, and community health initiatives, AHW drives change.
- Community Engagement
  Enhancing learning, research, patient care and the health of the community.
- Continuing Professional Development (CME)
  Develops applied learning experiences and supports continual education of the healthcare professional beyond graduation.
- Institute for Health & Equity
  A hub focused on population health, biostatistics, bioethics and epidemiology research.
- GMF-MCW Partnership
  Imagine a Milwaukee that is equitable, healthy and thriving for all.
Giving
- Advance Research
  We’re driving research that leads to improved diagnoses, more effective treatments, and new cures.
- Create Healthier Communities
  We work closely with partners to redefine health beyond healthcare and with a bold vision of achieving health equity for all.
- Healthcare Education
  We’re committed to meeting the needs of our changing population, and solving the significant healthcare provider shortage.
- Annual Fund For Excellence
  The flexibility of unrestricted funds allows MCW to continue addressing our most urgent priorities.
- Donate Now
  Your gift today makes tomorrow’s breakthroughs possible.
Find a Doctor

Visitors, including guests, contractors and vendors, to any MCW campus are asked to refrain from coming to campus. Badge-access is required to enter any campus building, and cloth face coverings must be worn in all common areas. All MCW-sponsored site visits or gatherings are cancelled.Coronavirus (COVID-19)

Home /
Education /
Graduate School /
Lishu He

Graduate Student

Locations

Pharmacology and Toxicology

Contact Information

lhe@mcw.edu

Biography

Mentor: Gwen Lomberk, PhD
Year Entered MCW: 2018
Previous Education: BS, Biology & Visual Culture, Syracuse University

Research Interests

My research focuses on epigenomic-based pharmacology and therapeutics in pancreatic cancer. Pancreatic cancer is projected to become the second leading cause of cancer death in the United States. Pancreatic adenocarcinoma (PDAC,) which accounts for most of the pancreatic cancer cases, is one of the most chemoresistant cancers and has not had sufficient therapeutics targeting molecular pathways linked to its development. I aim to explore standalone and/or combined inhibition of different genetic & epigenetic marks and signaling pathways as a potential source for new clinical trials and general PDAC treatment improvement.